Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, January 20, 2016
[ Wed, Jan 20th 2016
] - WOPRAI
Tue, January 19, 2016
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
[ Tue, Jan 19th 2016
] - WOPRAI
Brian Abrahams Downgraded (SRPT) to Hold and Decreased Target to $15 on, Jan 19th, 2016
Brian Abrahams of RBC Capital, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold and Decreased Target from $62 to $15 on, Jan 19th, 2016.
Brian has made no other calls on SRPT in the last 4 months.
There is 1 other peer that has a rating on SRPT. Out of the 1 peers that are also analyzing SRPT, all agrees with Brian's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Joseph Schwartz of "Leerink Swann" Maintained at Hold with Decreased Target to $27 on, Friday, November 6th, 2015
Similar Stocks and Investing Articles
[ Wed, Nov 25th 2015
] - WOPRAI
[ Mon, Nov 23rd 2015
] - WOPRAI
[ Fri, Nov 06th 2015
] - WOPRAI
[ Thu, Apr 23rd 2015
] - WOPRAI
[ Thu, Apr 16th 2015
] - WOPRAI
[ Tue, Feb 03rd 2015
] - WOPRAI
[ Wed, Jan 28th 2015
] - WOPRAI
[ Mon, Jan 06th 2014
] - WOPRAI
[ Tue, Nov 12th 2013
] - WOPRAI